BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 11605132)

  • 21. [Cost of care for depressive disorders in primary and specialized care in Germany].
    Salize HJ; Stamm K; Schubert M; Bergmann F; Härter M; Berger M; Gaebel W; Schneider F
    Psychiatr Prax; 2004 Apr; 31(3):147-56. PubMed ID: 15042478
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Costs of schizophrenia - what we know (not)?].
    Salize HJ
    Psychiatr Prax; 2001 Jul; 28 Suppl 1():S21-8. PubMed ID: 11533903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The impact of the study design and the sampling procedure on the assessment of mental health services].
    Kilian R; Roick C; Angermeyer MC
    Nervenarzt; 2003 Jul; 74(7):561-70. PubMed ID: 12861366
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cost-outcome of anxiety treatment intervention in primary care in Hungary.
    Zámbori J; Szádóczky E; Rózsa S; Füredi J
    J Ment Health Policy Econ; 2002 Sep; 5(3):115-20. PubMed ID: 12728198
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Developing rehabilitation treatment groups for cardiology and orthopaedics -- findings of a research project].
    Ranneberg J; Neubauer G
    Rehabilitation (Stuttg); 2005 Feb; 44(1):34-43. PubMed ID: 15668850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Patient characteristics, length of treatment and costs in a model institution of community mental health care].
    Dielentheis TF; Priebe S
    Psychiatr Prax; 2002 May; 29(4):186-93. PubMed ID: 12021991
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Outpatient costs of osteoporosis in a national health insurance population.
    Krappweis J; Rentsch A; Schwarz UI; Krobot KJ; Kirch W
    Clin Ther; 1999 Nov; 21(11):2001-14. PubMed ID: 10890269
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Living among strangers: the needs and functioning of persons with schizophrenia residing in an assisted living facility.
    Cadena SV
    Issues Ment Health Nurs; 2006 Jan; 27(1):25-41. PubMed ID: 16352514
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Medical economic impact of schizophrenia].
    Martin P
    Encephale; 1995 Jun; 21 Spec No 3():67-73. PubMed ID: 7628346
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The regional psychiatry budget: costs and effects of a new multisector financing model for psychiatric care].
    Roick C; Heinrich S; Deister A; Zeichner D; Birker T; Heider D; Schomerus G; Angermeyer MC; König HH
    Psychiatr Prax; 2008 Sep; 35(6):279-85. PubMed ID: 18773374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estimation of mental health care cost units for patients with schizophrenia.
    Saldivia Bórquez S; Torres González F; Cabasés Hita JM;
    Actas Esp Psiquiatr; 2005; 33(5):280-5. PubMed ID: 16155809
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Annual health outcomes and treatment costs for schizophrenia populations.
    Mauskopf JA; David K; Grainger DL; Gibson PJ
    J Clin Psychiatry; 1999; 60 Suppl 19():14-9; discussion 20-2. PubMed ID: 10507276
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The assessment of burden on relatives of mentally ill people: the German version of the involvement evaluation questionnaire (IEQ-EU)].
    Bernert S; Kilian R; Matschinger H; Mory C; Roick C; Angermeyer MC
    Psychiatr Prax; 2001 Oct; 28 Suppl 2():S97-101. PubMed ID: 11605131
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cost-effectiveness analysis of integrated care for people with HIV, chronic mental illness and substance abuse disorders.
    Weaver MR; Conover CJ; Proescholdbell RJ; Arno PS; Ang A; Uldall KK; Ettner SL
    J Ment Health Policy Econ; 2009 Mar; 12(1):33-46. PubMed ID: 19346565
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Organization of palliative medicine in the clinic and ambulatory care].
    Jonen-Thielemann I
    Zentralbl Chir; 1998; 123(6):640-8. PubMed ID: 9703639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Juvenile obesity and comorbidity type 2 diabetes mellitus (T2 DM) in Germany: development and cost-of-illness analysis].
    Wolfenstetter SB
    Gesundheitswesen; 2006 Oct; 68(10):600-12. PubMed ID: 17099820
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Comparing individual costs for treatment in acute day and inpatient care--results from a randomised controlled trial].
    Kallert TW; Schönherr R; Fröhling D; Schützwohl M
    Psychiatr Prax; 2007 Nov; 34(8):377-83. PubMed ID: 17671918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Insight in schizophrenia: assessment of 31 patients with different scales].
    Travers D; Levoyer D; Millet B
    Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
    Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
    J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.